1 Ocak 2023 Dergi makalesi Açık Erişim

Uzan, Gamze Sarikaya; Vural, Atay; Yuksel, Deniz; Aksoy, Erhan; Oztoprak, Ulkuhan; Canpolat, Mehmet; Ozturk, Selcan; Yildirim, Celebi; Gulec, Ayten; Per, Huseyin; Gumus, Hakan; Okuyaz, Cetin; Direk, Meltem Cobanoullari; Kosmur, Mustafa; Unalp, Aycan; Yilmaz, Unsal; Bektas, Omer; Teber, Serap; Aliyeva, Nargiz; Dundar, Nihal Olgac

DataCite XML

<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://datacite.org/schema/kernel-4" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.1/metadata.xsd">
  <identifier identifierType="URL">https://aperta.ulakbim.gov.tr/record/269172</identifier>
  <creators>
    <creator>
      <creatorName>Uzan, Gamze Sarikaya</creatorName>
      <givenName>Gamze Sarikaya</givenName>
      <familyName>Uzan</familyName>
      <affiliation>Dokuz Eylul Univ, Dept Pediat, Div Child Neurol, Fac Med, Izmir, Turkiye</affiliation>
    </creator>
    <creator>
      <creatorName>Vural, Atay</creatorName>
      <givenName>Atay</givenName>
      <familyName>Vural</familyName>
    </creator>
    <creator>
      <creatorName>Yuksel, Deniz</creatorName>
      <givenName>Deniz</givenName>
      <familyName>Yuksel</familyName>
      <affiliation>Univ Hlth Sci, Dr Sami Ulus Matern Child Hlth &amp; Dis Training &amp; Re, Fac Med, Dept Pediat Neurol, Ankara, Turkiye</affiliation>
    </creator>
    <creator>
      <creatorName>Aksoy, Erhan</creatorName>
      <givenName>Erhan</givenName>
      <familyName>Aksoy</familyName>
      <affiliation>Univ Hlth Sci, Dr Sami Ulus Matern Child Hlth &amp; Dis Training &amp; Re, Fac Med, Dept Pediat Neurol, Ankara, Turkiye</affiliation>
    </creator>
    <creator>
      <creatorName>Oztoprak, Ulkuhan</creatorName>
      <givenName>Ulkuhan</givenName>
      <familyName>Oztoprak</familyName>
    </creator>
    <creator>
      <creatorName>Canpolat, Mehmet</creatorName>
      <givenName>Mehmet</givenName>
      <familyName>Canpolat</familyName>
      <affiliation>Erciyes Univ, Dept Pediat, Div Child Neurol, Fac Med, Kayseri, Turkiye</affiliation>
    </creator>
    <creator>
      <creatorName>Ozturk, Selcan</creatorName>
      <givenName>Selcan</givenName>
      <familyName>Ozturk</familyName>
      <affiliation>Erciyes Univ, Dept Pediat, Div Child Neurol, Fac Med, Kayseri, Turkiye</affiliation>
    </creator>
    <creator>
      <creatorName>Yildirim, Celebi</creatorName>
      <givenName>Celebi</givenName>
      <familyName>Yildirim</familyName>
      <affiliation>Erciyes Univ, Dept Pediat, Fac Med, Kayseri, Turkiye</affiliation>
    </creator>
    <creator>
      <creatorName>Gulec, Ayten</creatorName>
      <givenName>Ayten</givenName>
      <familyName>Gulec</familyName>
      <affiliation>Erciyes Univ, Dept Pediat, Div Child Neurol, Fac Med, Kayseri, Turkiye</affiliation>
    </creator>
    <creator>
      <creatorName>Per, Huseyin</creatorName>
      <givenName>Huseyin</givenName>
      <familyName>Per</familyName>
    </creator>
    <creator>
      <creatorName>Gumus, Hakan</creatorName>
      <givenName>Hakan</givenName>
      <familyName>Gumus</familyName>
      <affiliation>Erciyes Univ, Dept Pediat, Div Child Neurol, Fac Med, Kayseri, Turkiye</affiliation>
    </creator>
    <creator>
      <creatorName>Okuyaz, Cetin</creatorName>
      <givenName>Cetin</givenName>
      <familyName>Okuyaz</familyName>
      <affiliation>Mersin Univ, Dept Pediat, Div Child Neurol, Fac Med, Mersin, Turkiye</affiliation>
    </creator>
    <creator>
      <creatorName>Direk, Meltem Cobanoullari</creatorName>
      <givenName>Meltem Cobanoullari</givenName>
      <familyName>Direk</familyName>
      <affiliation>Mersin Univ, Dept Pediat, Div Child Neurol, Fac Med, Mersin, Turkiye</affiliation>
    </creator>
    <creator>
      <creatorName>Kosmur, Mustafa</creatorName>
      <givenName>Mustafa</givenName>
      <familyName>Kosmur</familyName>
    </creator>
    <creator>
      <creatorName>Unalp, Aycan</creatorName>
      <givenName>Aycan</givenName>
      <familyName>Unalp</familyName>
      <affiliation>Univ Hlth Sci Dr Behcet Uz Child Dis &amp; Pediat Surg, Dept Pediat, Div Pediat Neurol, Izmir, Turkiye</affiliation>
    </creator>
    <creator>
      <creatorName>Yilmaz, Unsal</creatorName>
      <givenName>Unsal</givenName>
      <familyName>Yilmaz</familyName>
      <affiliation>Univ Hlth Sci Dr Behcet Uz Child Dis &amp; Pediat Surg, Dept Pediat, Div Pediat Neurol, Izmir, Turkiye</affiliation>
    </creator>
    <creator>
      <creatorName>Bektas, Omer</creatorName>
      <givenName>Omer</givenName>
      <familyName>Bektas</familyName>
      <affiliation>Ankara Univ, Dept Pediat, Div Child Neurol, Fac Med, Ankara, Turkiye</affiliation>
    </creator>
    <creator>
      <creatorName>Teber, Serap</creatorName>
      <givenName>Serap</givenName>
      <familyName>Teber</familyName>
      <affiliation>Ankara Univ, Dept Pediat, Div Child Neurol, Fac Med, Ankara, Turkiye</affiliation>
    </creator>
    <creator>
      <creatorName>Aliyeva, Nargiz</creatorName>
      <givenName>Nargiz</givenName>
      <familyName>Aliyeva</familyName>
      <affiliation>Univ Hlth Sci Tepecik Res &amp; Training Hosp, Dept Pediat, Div Pediat Neurol, Izmir, Turkiye</affiliation>
    </creator>
    <creator>
      <creatorName>Dundar, Nihal Olgac</creatorName>
      <givenName>Nihal Olgac</givenName>
      <familyName>Dundar</familyName>
      <affiliation>Izmir Katip Celebi Univ, Dept Pediat, Div Child Neurol, Fac Med, Izmir, Turkiye</affiliation>
    </creator>
  </creators>
  <titles>
    <title>Pediatric-Onset Chronic Inflammatory Demyelinating Polyneuropathy: A Multicenter Study</title>
  </titles>
  <publisher>Aperta</publisher>
  <publicationYear>2023</publicationYear>
  <dates>
    <date dateType="Issued">2023-01-01</date>
  </dates>
  <resourceType resourceTypeGeneral="Text">Journal article</resourceType>
  <alternateIdentifiers>
    <alternateIdentifier alternateIdentifierType="url">https://aperta.ulakbim.gov.tr/record/269172</alternateIdentifier>
  </alternateIdentifiers>
  <relatedIdentifiers>
    <relatedIdentifier relatedIdentifierType="DOI" relationType="IsIdenticalTo">10.1016/j.pediatrneurol.2023.04.018</relatedIdentifier>
  </relatedIdentifiers>
  <rightsList>
    <rights rightsURI="http://www.opendefinition.org/licenses/cc-by">Creative Commons Attribution</rights>
    <rights rightsURI="info:eu-repo/semantics/openAccess">Open Access</rights>
  </rightsList>
  <descriptions>
    <description descriptionType="Abstract">&lt;p&gt;Background: To evaluate the clinical features, demographic features, and treatment modalities of pediatric-onset chronic inflammatory demyelinating polyneuropathy (CIDP) in Turkey. Methods: The clinical data of patients between January 2010 and December 2021 were reviewed retrospectively. The patients were evaluated according to the Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society Guideline on the management of CIDP (2021). In addition, patients with typical CIDP were divided into two groups according to the first-line treatment modalities (group 1: IVIg only, group 2: IVIg + steroid). The patients were further divided into two separate groups based on their magnetic resonance imaging (MRI) characteristics. Results: A total of 43 patients, 22 (51.2%) males and 21 (48.8%) females, were included in the study. There was a significant difference between pretreatment and post-treatment modified Rankin scale (mRS) scores (P &amp;lt; 0.05) of all patients. First-line treatments include intravenous immunoglobulin (IVIg) (n = 19, 4 4.2%), IVIg + steroids (n = 20, 46.5%), steroids (n = 1, 2.3%), IVIg + steroids + plasmapheresis (n = 1, 2.3%), and IVIg + plasmapheresis (n = 1, 2.3%). Alternative agent therapy consisted of azathioprine (n = 5), rituximab (n = 1), and azathioprine + mycophenolate mofetil + methotrexate (n = 1). There was no difference between the pretreatment and post-treatment mRS scores of groups 1 and 2 (P &amp;gt; 0.05); however, a significant decrease was found in the mRS scores of both groups with treatment (P &amp;lt; 0.05). The patients with abnormal MRI had significantly higher pretreatment mRS scores compared with the group with normal MRI (P &amp;lt; 0.05). Conclusions: This multicenter study demonstrated that first-line immunotherapy modalities (IVIg vs IVIg + steroids) had equal efficacy for the treatment of patients with CIDP. We also determined that MRI features might be associated with profound clinical features, but did not affect treatment response. &amp;amp; COPY; 2023 Elsevier Inc. All rights reserved.&lt;/p&gt;</description>
  </descriptions>
</resource>